Magnus von Knebel Doeberitz

Magnus von Knebel Doeberitz's AcademicInfluence.com Rankings

Biology

#6584

World Rank

#9335

Historical Rank

Virology

#274

World Rank

#281

Historical Rank

Molecular Biology

#1739

World Rank

#1768

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Magnus von Knebel Doeberitz Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Magnus von Knebel Doeberitz is a molecular oncologist and virologist, a professor of molecular oncology and medical director of the Department of Applied Tumor Biology at the Institute of Pathology at the University Hospital of Heidelberg. He also heads a Clinical Cooperation at the German Cancer Research Center.

(See a Problem?)

Magnus von Knebel Doeberitz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri (2001) (1056)
Potential of fecal microbiota for early-stage detection of colorectal cancer (2014) (793)
p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia (2002) (455)
Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract (2004) (453)
Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. (1999) (415)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. (2008) (316)
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. (1988) (297)
Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. (2008) (288)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2019) (280)
A systematic review of humoral immune responses against tumor antigens (2009) (264)
Risks of less common cancers in proven mutation carriers with lynch syndrome. (2012) (258)
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. (2004) (252)
Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases (2005) (232)
Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. (1999) (230)
Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV e6‐e7 anti‐sense RNA (1992) (227)
Biomarkers in Cervical Cancer Screening (2007) (224)
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. (2002) (219)
Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens (2001) (212)
Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. (2003) (204)
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. (2002) (184)
A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques (2003) (179)
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study (2013) (178)
Wnt/β‐catenin‐pathway as a molecular target for future anti‐cancer therapeutics (2005) (177)
Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. (2010) (172)
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta‐analysis (2017) (159)
The Immune Biology of Microsatellite-Unstable Cancer. (2016) (158)
Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells (2001) (155)
Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high‐risk human papillomavirus (2003) (151)
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions (1994) (151)
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. (2009) (149)
Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. (2005) (148)
Tumor suppressor p16INK4a − modulator of glycomic profile and galectin‐1 expression to increase susceptibility to carbohydrate‐dependent induction of anoikis in pancreatic carcinoma cells (2007) (147)
DNA Aneuploidy and Integration of Human Papillomavirus Type 16 E6/E7 Oncogenes in Intraepithelial Neoplasia and Invasive Squamous Cell Carcinoma of the Cervix Uteri (2004) (146)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol (2012) (143)
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. (2004) (140)
Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions (2002) (138)
New technologies and procedures for cervical cancer screening. (2012) (137)
Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. (1991) (134)
Immune evasion of microsatellite unstable colorectal cancers (2010) (131)
Cancer Risks for PMS2-Associated Lynch Syndrome. (2018) (128)
T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. (2005) (126)
Evaluation of a nuclear score for p16INK4a‐stained cervical squamous cells in liquid‐based cytology samples (2005) (125)
Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. (2012) (125)
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability (2008) (116)
BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer (2013) (113)
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms (2015) (106)
The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments (2015) (104)
Three molecular pathways model colorectal carcinogenesis in Lynch syndrome (2018) (103)
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells. (2005) (103)
Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions (2013) (101)
Beta2‐microglobulin mutations in microsatellite unstable colorectal tumors (2007) (98)
Determination of structural and functional overlap/divergence of five proto‐type galectins by analysis of the growth‐regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells (2005) (97)
Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. (2005) (97)
Triage of women with ASCUS and LSIL cytology (2006) (97)
Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis. (1999) (95)
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. (1999) (93)
No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies. (2018) (89)
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. (2016) (88)
Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation (2011) (88)
Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. (2005) (87)
A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors. (1996) (87)
Biomarkers for cervical cancer screening: the role of p16INK4a to highlight transforming HPV infections (2012) (86)
Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells. (2004) (85)
The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy. (2009) (85)
Morphologic Characteristics of p16INK4a-Positive Cells in Cervical Cytology Samples (2004) (83)
The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. (2008) (82)
Complex pattern of immune evasion in MSI colorectal cancer (2018) (81)
Microsatellite instability in the development of DNA mismatch repair deficient tumors. (2006) (80)
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis. (2014) (80)
Detection and clinical relevance of micrometastatic cancer cells (2000) (76)
WT1 is a tumor‐associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells (2004) (76)
Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki‐67 in epithelial cells (2012) (73)
Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer (2006) (72)
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities (2012) (71)
A rapid microscale procedure for the simultaneous preparation of cytoplasmic RNA, nuclear DNA binding proteins and enzymatically active luciferase extracts. (1991) (69)
Nuclear accumulation of β‐catenin protein in Wilms' tumours † (2003) (68)
Detection of Hematogenous Tumor Cell Dissemination Predicts Tumor Relapse in Patients Undergoing Surgical Resection of Colorectal Liver Metastases (2005) (68)
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial (2012) (68)
Combined molecular and clinical approaches for the identification of families with familial adenomatous polyposis coli. (1999) (67)
Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwest Germany (1998) (66)
Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. (2001) (66)
CD56‐positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma (2016) (66)
Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results. (2010) (65)
European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. (2020) (65)
No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer (1999) (64)
New Molecular Tools for Efficient Screening of Cervical Cancer (2002) (63)
CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome (2016) (60)
Clinical significance of microsatellite instability in colorectal cancer (2013) (59)
Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. (2009) (59)
High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients (2011) (58)
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. (2000) (58)
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution (2020) (57)
Characterization of contaminating DNA in Taq polymerase which occurs during amplification with a primer set for Legionella 5S ribosomal RNA. (1994) (57)
Analysis of EPCAM protein expression in diagnostics of Lynch syndrome. (2011) (57)
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP‐specific RT‐PCR (2001) (56)
Decreased Detection Rate of Disseminated Tumor Cells of Rectal Cancer Patients After Preoperative Chemoradiation: A First Step Towards a Molecular Surrogate Marker for Neoadjuvant Treatment in Colorectal Cancer (2003) (56)
Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome – Molecular Alterations and Association with Clinical Parameters (2015) (56)
Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer. (2014) (56)
Towards a vaccine to prevent cancer in Lynch syndrome patients (2013) (55)
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome (2010) (55)
p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement. (2014) (55)
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma (2018) (55)
Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus (2019) (55)
Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer (2017) (54)
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes (2010) (53)
Expression of an endogenous retroviral sequence from the HERV‐H group in gastrointestinal cancers (2007) (51)
Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. (2000) (51)
The Wnt signaling pathway in solid childhood tumors. (2003) (50)
Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression. (1999) (49)
Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair‐deficient cancer cells (2001) (49)
Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer (2011) (48)
Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. (2013) (48)
p16INK4a/Ki‐67 co‐expression specifically identifies transformed cells in the head and neck region (2015) (47)
Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. (2005) (46)
Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy (2019) (45)
Methylation status of HPV16 E2‐binding sites classifies subtypes of HPV‐associated oropharyngeal cancers (2015) (44)
T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer (2012) (44)
Identification of high‐grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples (2006) (43)
Comparison of polymerase chain reaction and conventional culture for the detection of legionellas in hospital water samples. (1994) (43)
Microsatellite Instability in Pediatric and Adult High‐grade Gliomas (2007) (42)
The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC) (2005) (42)
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. (2020) (41)
Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system. (1999) (41)
Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations. (2017) (40)
Identification of differentially expressed genes in colorectal adenoma compared to normal tissue by suppression subtractive hybridization. (2004) (39)
A phase 1/2a study to test the safety and immunogenicity of a p16INK4a peptide vaccine in patients with advanced human papillomavirus‐associated cancers (2016) (39)
HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is Associated With an Aggressive Clinical Course (2017) (39)
A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial (2020) (39)
Nuclear accumulation of beta-catenin protein in Wilms' tumours. (2003) (36)
P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. (2008) (36)
Detection of C trachomatis in urogenital specimens by polymerase chain reaction. (1991) (35)
p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. (1996) (35)
Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. (1996) (35)
Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability (2008) (34)
p16 methylation does not affect protein expression in cervical carcinogenesis. (2008) (34)
Dexamethasone-Induced Enhancement of Resistance to Ionizing Radiation and Chemotherapeutic Agents in Human Tumor Cells (1999) (34)
Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway. (2010) (33)
A Virtual Microscopy System to Scan, Evaluate and Archive Biomarker Enhanced Cervical Cytology Slides (2010) (32)
Expression profiling of CC531 colon carcinoma cells reveals similar regulation of β‐catenin target genes by both butyrate and aspirin (2003) (32)
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer (2015) (32)
Detection of Epstein-Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients. (1991) (32)
A large MSH2 Alu insertion mutation causes HNPCC in a German kindred (2004) (32)
The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance (2020) (31)
Oncogenic Human Papillomaviruses Activate the Tumor-Associated Lens Epithelial-Derived Growth Factor (LEDGF) Gene (2014) (31)
Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. (1990) (31)
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells. (2003) (30)
Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients. (2008) (30)
Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation (2009) (30)
The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. (2007) (29)
Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells (1990) (28)
Characterization of Squamous Cell Cancers of the Vulvar Anterior Fourchette by Human Papillomavirus, p16INK4a, and p53 (2013) (28)
Molecular profiling of sporadic colorectal tumors by microsatellite analysis. (2000) (28)
p16 Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia (2002) (27)
Recurrent frameshift neoantigen vaccine elicits protective immunity with reduced tumor burden and improved overall survival in a Lynch syndrome mouse model. (2021) (27)
Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia (2019) (26)
Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies (2011) (26)
GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers (2015) (25)
Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer (2016) (25)
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study (2020) (25)
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes (1999) (25)
Obligation for cell line authentication: Appeal for concerted action (2010) (24)
Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. (1995) (24)
Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study. (2007) (23)
and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells (2007) (23)
Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation (2020) (23)
Role of DNA methylation in HPV associated lesions (2019) (22)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report (2019) (22)
No Metastatic Cervical Adenocarcinomas in a Series of p16INK4a-Positive Mucinous or Endometrioid Advanced Ovarian Carcinomas: An Analysis of the AGO Ovarian Cancer Study Group (2008) (22)
Nucleic Acid Based Techniques for the Detection of Rare Cancer Cells in Clinical Samples (1999) (21)
Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies (2016) (21)
5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells (2016) (21)
Combined serial section‐based 3D reconstruction of cervical carcinoma invasion using H&E/p16INK4a/CD3 alternate staining (2007) (21)
Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry. (2002) (21)
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study. (2021) (21)
Interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer. (1997) (20)
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer. (1998) (20)
ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism (2017) (20)
European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. (2021) (20)
Prospective clinical study comparing DNA flow cytometry and HPV typing as predictive tests for persistence and progression of CIN I/II. (2001) (20)
Low frequency of mismatch repair deficiency in gallbladder cancer (2019) (20)
A Phase I/IIa trial of a frameshift peptide neoantigen-based vaccine for mismatch repair-deficient cancers. (2020) (20)
Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2. (1999) (19)
Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains (2020) (19)
Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies. (1997) (19)
Nuclear Accumulation of β-Catenin Protein Indicates Activation of wnt Signaling in Chemically Induced Rat Nephroblastomas (2010) (18)
Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. (1999) (18)
No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status. (2014) (18)
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report (2020) (18)
Molecular Analysis of Endometrial Hyperplasia in HNPCC-suspicious Patients May Predict Progression to Endometrial Carcinoma (2004) (18)
Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer (2007) (17)
Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma (2020) (17)
Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells. (1996) (17)
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. (2005) (17)
The causal role of human papillomavirus infections in non‐anogenital cancers. It's time to ask for the functional evidence. (2016) (16)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2019) (15)
The causal role of human papillomavirus infections in non-anogenital cancers. It's time to ask for the functional evidence. (2016) (15)
The different immune profiles of normal colonic mucosa in cancer-free Lynch syndrome carriers and Lynch syndrome colorectal cancer patients (2021) (15)
Analysis of p16INK4a and integrated HPV genomes as progression markers. (2005) (15)
A network of conserved co-occurring motifs for the regulation of alternative splicing (2010) (14)
High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer (2019) (14)
Diagnostic tests for the detection of human papillomavirus-associated cervical lesions. (2013) (13)
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes (2021) (13)
Molecular tools in the detection of micrometastatic cancer cells--technical aspects and clinical relevance. (2001) (13)
Detection of Disseminated Medullary Thyroid Carcinoma Cells inCervical Lymph Nodes by Cytokeratin 20 Reverse Transcription-PolymeraseChain Reaction (2002) (13)
Age‐dependent performance of BRAF mutation testing in Lynch syndrome diagnostics (2020) (13)
N-acetyltransferase (NAT) 2 acetylator status and age of onset in patients with hereditary nonpolyposis colorectal cancer (HNPCC). (2006) (13)
Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review (2020) (13)
Molecular testing for microsatellite instability and its value in tumor characterization (2005) (12)
Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis. (1992) (12)
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study (2021) (11)
p16INK4a/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya (2015) (11)
A simplified solid-phase assay for the quantitation of native membrane proteins. Application to the measurement of EGF receptor induction by dexamethasone. (1989) (11)
Tetranucleotide repeats in coding regions: no evidence for involvement in EMAST carcinogenesis (2006) (11)
Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia (2020) (11)
The Role of Cytology in the 21st Century: The Integration of Cells and Molecules (2016) (11)
Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis. (1992) (11)
Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya (2020) (11)
Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies. (2013) (10)
Identification and characterization of UEV3, a human cDNA with similarities to inactive E2 ubiquitin-conjugating enzymes. (2002) (10)
State of Human Papilloma Virus DNA in Cervical Carcinomas (2004) (10)
Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin‐releasing peptide RT‐PCR (2003) (10)
Dose‐dependent effect of 2‐deoxy‐D‐glucose on glycoprotein mannosylation in cancer cells (2015) (10)
[HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development]. (2011) (10)
Biomarkers in Screening of Cervical Cancer (2006) (9)
Identification of differentially expressed genes after partial rat liver ischemia/reperfusion by suppression subtractive hybridization. (2005) (9)
Analysis of the biological role of human papilloma virus (HPV)-encoded transcripts in cervical carcinoma cells by antisense RNA. (1987) (9)
[Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies]. (1997) (9)
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report (2021) (9)
Papillomaviruses in human disease: Part I. Pathogenesis and epidemiology of human papillomavirus infections. (1992) (8)
Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients. (2004) (8)
The German quality assurance system for the molecular-pathological detection of KRAS-mutations in colorectal cancer. (2016) (8)
The Cell: Basic Structure and Function (2008) (8)
German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions (2021) (8)
Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells (2009) (8)
Induction of an Antitumoral Immune Response by Wild-Type Adeno-Associated Virus Type 2 in an In Vivo Model of Pancreatic Carcinoma (2007) (7)
[The p16INK4a protein: a cytological marker for detecting high grade intraepithelial neoplasia of the uterine cervix]. (2006) (7)
Beta-2-microglobulin Mutations Are Linked to a Distinct Metastatic Pattern and a Favorable Outcome in Microsatellite-Unstable Stage IV Gastrointestinal Cancers (2021) (7)
A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens (2014) (7)
Overexpression of p16INK4a Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated With Radiotherapy Irrespective of HPV-Status (2019) (7)
[Molecular pathogenesis of cervical cancer and its first steps]. (2005) (7)
Detection of the human papillomavirus 58 physical state using the amplification of papillomavirus oncogene transcripts assay. (2013) (7)
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium (2022) (7)
Image Registration of Differently Stained Histological Sections (2006) (7)
Phase I/IIa trial targeting p16INK4a by peptide vaccination in patients with human papillomavirus-associated cancer. (2015) (6)
APOBEC3A Expression in Penile Squamous Cell Carcinoma (2017) (6)
Traditional and new molecular methods for early detection of cervical cancer. (2004) (6)
Papillomaviruses in human disease: Part I. Pathogenesis and epidemiology of human papillomavirus infections. (1992) (6)
Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers (2008) (6)
Prevention of chemotherapy‐related toxic side effects by infection with adeno‐associated virus type 2 (2002) (5)
Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study (2016) (5)
Human papillomavirus early gene products and maintenance of the transformed state of cervical cancer cells in vitro. (1989) (5)
[Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications]. (2016) (5)
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2020) (5)
Searching for new biomarkers for cervical cancer: Molecular accidents and the interplay of papillomavirus oncogenes and epithelial differentiation - Part II (2002) (5)
Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018. (2014) (5)
Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure (2020) (5)
The shared neoantigen landscape of MSI cancers reflects immunoediting during tumor evolution (2019) (5)
[Aspects of molecular pathogenesis of cervical cancer in establishing new tumor markers for early detection and diagnosis]. (2001) (4)
The coding microsatellite mutation profile of PMS2-deficient colorectal cancer. (2021) (4)
Evaluation of the detection ofBorrelia burgdorferi DNA in urine samples by polymerase chain reaction (1995) (4)
Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A (1983) (4)
Molecular markers of cervical squamous cell cancer precursor lesions (2006) (4)
[Status of the human DNA papillomavirus in cervical tumors]. (2001) (4)
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort Effect (2019) (4)
[Viral carcinogenesis of head and neck tumors]. (2004) (4)
Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure. (2021) (3)
Prognostic value of high-risk human papillomavirus DNA and p16INK4a immunohistochemistry in patients with anal cancer: An individual patient data meta-analysis. (2021) (3)
(Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A (2020) (3)
[The role of papillomaviruses in the etiology of cervix cancer]. (1990) (3)
Coding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review (2015) (3)
P16INK4a is a tumor autoantigen in HR-HPV induced cancers (2005) (3)
Conflicts of interest: The responsibility of the authors and editors of the International Journal of Cancer (2006) (3)
Dexamethasone-Enhanced Cisplatin Resistance of Human Lung Carcinoma Cells (1995) (3)
Vaccination against HPV-Associated Neoplasias (2014) (3)
Towards a vaccine to prevent cancer in Lynch syndrome patients (2013) (2)
New molecular tools for efficient screening of cervical cancer. (2001) (2)
Erratum: Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer (International Journal of Cancer (2006) 118 (3072-3077)) (2006) (2)
Is HLA type a possible cancer risk modifier in Lynch syndrome? (2022) (2)
PREPARATION OF 2-DEOXY-D-GLUCOSE COATED SPIO NANOPARTICLES AND CHARACTERIZATION OF THEIR PHYSICAL , CHEMICAL , AND BIOLOGICAL PROPERTIES (2014) (2)
Characterization of humoral immune responses against p16 in HPV-associated and non HPV-associated disease (2008) (2)
Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53. (2020) (2)
[Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma]. (2000) (2)
[Detection of isolated disseminated tumor cells of colorectal carcinomas in lymph nodes]. (2000) (2)
p16INK4a IHC in the diagnosis of cervical CIN. Author's reply (2003) (2)
OCCULT LOCAL TUMOR SPREAD IN CERVICAL CANCER PATIENTS (2004) (2)
HPV 16 and its variants: minor genome variations make a big difference. (2016) (2)
[Effect of molecular diagnostic procedures on surgical therapy of malignant diseases]. (1996) (2)
HPV in anal cancer Inﬂuence of human papillomavirus and p16 INK4a on treatment outcome of patients with anal cancer (2014) (2)
Improved blunt-end cloning by replacing EcoRV with Eco32I. (2002) (2)
CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome (2016) (2)
A simple approach for detecting HLA‐A*02 alleles in archival formalin‐fixed paraffin‐embedded tissue samples and an application example for studying cancer immunoediting (2022) (1)
Biological Significance of Human Papillomavirus Early Gene Expression in Human Cervical Carcinoma Cells (1990) (1)
Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation (2019) (1)
BRAFmutation testing of MSI CRCs in Lynch syndrome diagnostics: performance and efficiency according to patient’s age (2019) (1)
HPV 16 and its variants: minor genome variations make a big difference (2016) (1)
The Influence of HPV-Status on Outcome of Anal Cancer Treated with Radio-Chemotherapy (2014) (1)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report (2019) (1)
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma (2018) (1)
Adenoma and colorectal cancer risks in Lynch syndrome, Lynch‐like syndrome and familial colorectal cancer type X (2021) (1)
Phase I/IIa study of therapeutic p16INK4a vaccination in patients with HPV-associated cancers. (2014) (1)
Abstract A006: Frameshift peptide neoantigens as vaccine targets in microsatellite-unstable cancers (2016) (1)
Screening for cancer. (2010) (1)
[Molecular cell biology--basis for new diagnostic and therapeutic approaches in surgical oncology]. (1998) (1)
[Vaccination against HPV-associated neoplasias]. (2014) (1)
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies (2023) (1)
Pharmacological inhibition of nonsense-mediated RNA decay augments HLA class I-mediated presentation of neoepitopes in MSI CRC (2020) (1)
Prognostic significance of p16INK4a expression and integrated human papillomavirus oncogen transcripts in dysplastic lesions of the uterine cervix (2003) (1)
Correction: Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation (2021) (1)
Papillomaviruses and Human Cancer (1991) (1)
Color atlas of histopathology of the cervix uteri [electronic resource] / Gisela Dallenbach-Hellweg, Magnus von Knebel Doeberitz, Marcus J. Trunk (2005) (1)
A Platform and Multisided Market for Translational, Software-Defined Medical Procedures in the Operating Room (OP 4.1): Proof-of-Concept Study (2021) (1)
[Cervical cancer is preventable today]. (2021) (1)
Abstract A12: Vicoryx: A phase I/IIa clinical trial using a p16INK4a derived peptide as vaccine in patients with advanced human papillomavirus-associated cancer (2013) (1)
Improved systemic antitumor effect provided by adeno-associated virus type 2 (aav-2)-infection in lewis rats with pancreatic carcinoma (2001) (0)
Is progression of HPV-infected cells within the cervical epithelium linked to modified interaction with the extracellular matrix? The potential role of the 67-kd nonintegrin laminin receptor 67LR. (2006) (0)
Method for diagnosis based on a solution. (2002) (0)
Strategies for the molecular diagnosis of colorectal cancers (1997) (0)
Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region (2023) (0)
INK 4 a p 16 / Ki-67 dual stain cytology for cervical cancer screening in Thika district , Kenya (2015) (0)
Issue Information (2019) (0)
Synergistic effect of p53 adenovirus-mediated gene therapy and 5-fu-chemotherapy in the treatment of pancreatic cancer (2001) (0)
Issue Information (2018) (0)
Abstracts from USCAP 2019: Dermatopathology (466-505) (2019) (0)
Is Progression of HPV-Infected Cells Within the Cervical Epithelium Linked to Modified Interaction with the Extracellular Matrix? (2006) (0)
p16INK4a/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya (2015) (0)
Issue Information (2019) (0)
Der Nachweis hämatogen disseminierter Tumorzellen als prognostischer Marker für das Tumorrezidiv bei Patienten nach Resektion kalorektaler Lebermetastasen Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastase (2003) (0)
Integration of human papilloma virus as a monoclonal event in cervical cancer (2005) (0)
Abstract 5306: p16INH4astatus helps predict clinical outcome of dysplasia in the oral cavity irrespective of HPV status (2017) (0)
Disease Markers: Foreword (2007) (0)
PP-1261 DETECTION OF ISOLATED DISSEMINATED TUMOR CELLS IN PATIENTS WITH HCC BY AFP-RT-PCR (2000) (0)
Issue Information (2018) (0)
p16INK4a immunocytochemistry — a novel tool in cervical cytology (2004) (0)
Issue Information (2018) (0)
Use of p16INK4a Cytology as a Triage Tool for the Detection of High-grade Cervical Intraepithelial Neoplasia in Women with Atypical Squamous Cells of Undetermined Significance or Low-grade Squamous Intraepithelial Cell Cytology (2006) (0)
A "two-in-one hit" model of shortcut carcinogenesis in MLH1 Lynch syndrome carriers. (2023) (0)
Issue Information (2019) (0)
Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillance (2020) (0)
42 CD56-positive lymphocyte infiltration in correlation with outcome and human papilloma virus association of oropharyngeal squamous cell carcinoma (2015) (0)
Issue Information (2018) (0)
Issue Information (2019) (0)
Concepts of Biomarker Development (2012) (0)
International Journal of Cancer: Editorial (2008) (0)
Molecular pathogenesis of lung cancer: Implications for early diagnosis by new screening tests (1994) (0)
Metaplasia method to differentiate neoplastic or pre-neoplastic lesions. (2003) (0)
A Platform and Multi-sided Market for Translational, Software-defined Medical Research in the Operation Room: OP 4.1 (Preprint) (0)
The dawn of prophylactic vaccines against human papillomaviruses and cervical cancer. (2006) (0)
A computational model for investigating the evolution of colonic crypts during Lynch syndrome carcinogenesis (2020) (0)
Contributor Index Vol. 48, 2004 (2004) (0)
P16 Specific IFN-gamma Secreting T Cells in Tumor Infiltrating Populations of Cervical Intraepithelial Neoplasia (CIN) and Cervical Cancer (2006) (0)
Issue Information (2018) (0)
HPV status to predict outcome for anal cancer treated with radiochemotherapy. (2013) (0)
Sensitive detection of few vital small cell lung cancer (SCLC) cells in blood and sputum by RT-PCR (2007) (0)
Treatment resistance analysis reveals GLUT‐1‐mediated glucose uptake as a major target of synthetic rocaglates in cancer cells (2021) (0)
Procedure for discrimination between metaplasia and neoplastic or pre-neoplastic lesions. (2003) (0)
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol (2012) (0)
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study (2020) (0)
Issue Information (2019) (0)
Subject Index Vol. 48, 2004 (2004) (0)
Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya (2020) (0)
Immunohistochemistry and In Situ Hybridization (2006) (0)
Subject Index Vol. 60, 2016 (2016) (0)
Abstract 828: Methylation status of HPV16 E2-binding sites identifies subtypes of HPV-associated oropharyngeal squamous cell carcinomas (2015) (0)
Molekulare Pathogenese (2008) (0)
Introduction of a 3D-organotypic co-culture model for head and neck squamous cell carcinoma (2019) (0)
The pathogenesis of human papillomaviruses associated cancers – theoretical concepts and clinical applications (2008) (0)
Expression of variant spliced CD44 transcripts in normal dysplastic and neoplastic cervical epithelium (2007) (0)
Low Frequency of Mismatch Repair Deficiency in a Large Cohort of Non-liver fluke associated Cholangiocarcinomas (2018) (0)
Rapid and sensitive non-radioactive detection of mutant K-ras genes in clinical samples by mutant enriched PCR amplification (2007) (0)
Characterization of P53 activities in cervial carcinoma cells with and without HPV oncogene expression (2007) (0)
Genetic analysis of the growth promoting functions of the papillomavirus oncogenes E6 and E7 in a cervical carcinoma cell line (2007) (0)
Analysis of “integrated type” versus “episomal type” HPV mRNAs in premalignant and malignant lesions of the uterine cervix (2007) (0)
Foreword (2007) (0)
Molecular analysis of growth regulatory functions of papillomavirus oncogenes E6 and E7 in cervical cancer cells (2007) (0)
The dawn of prophylactic vaccines against human papillomaviruses and cervical cancer (2006) (0)
Editorial (2009) (0)
Editorial (2008) (0)
Reply to ‘Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer” (2018) (0)
CD44 variant expression in human lung cancer and normal bronchial epithelium (2007) (0)
Senescent tumor cells are frequently present at the invasion front - implications for improving disease control in patients with locally advanced prostate cancer. (2023) (0)
Screening for cancer. (2010) (0)
Contents Vol. 60, 2016 (2016) (0)
Evaluation of an Enzyme-linked Immunosorbent Assay-based p16INK4a Detection Assay for the Identification of High-grade Cervical Intraepithelial Neoplasia in Women Attending a Cervical Dysplasia Outpatient Clinic (2006) (0)
Perspectives in prevention of HPV-induced cervical cancer (2006) (0)
Co-expression of p16INK4a and Ki-67 in identical cells of cervical lesions as an independent sign of dysplasia (2004) (0)
Screening for Cervical Cancer Precursors to Prevent Invasive Disease (2006) (0)
Issue Information (2018) (0)
[Molecular pathogenesis. Its importance in targeted therapy in colorectal cancer]. (2008) (0)
Issue Information (2019) (0)
Inhibition of cisplatin-induced apoptosis by dexamethasone in cervical and bronchial carcinoma cells (1997) (0)
primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study (2017) (0)
Subject Index Vol. 60, Vol. 6, 2016 (2016) (0)
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database (2023) (0)
P32 Prospective study on human papillomavirus significance in oral dysplasias in association with clinical parameters and P16INK4a expression (2015) (0)
Issue Information (2018) (0)
Detection of Legionella sp. in water by means of polymerase chain reaction: establishing the methodology (1992) (0)
Abstract A18: Defining ovarian mucinous tumors: Cancer genes and heterogeneity (2013) (0)
Altered Expression of UDP-N-Acetyl-D-galactosamine:Polypeptide N-Acetylgalactosaminyltransferases in Cervical Cancer (2007) (0)
Issue Information (2017) (0)
Issue Information (2019) (0)
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER (1999) (0)
Human papillomaviruses and cervical cancer (2007) (0)
Issue Information (2018) (0)
Immunization against carcinomas and previous. (2001) (0)

This paper list is powered by the following services:

Other Resources About Magnus von Knebel Doeberitz

en.wikipedia.org

What Schools Are Affiliated With Magnus von Knebel Doeberitz?

Magnus von Knebel Doeberitz is affiliated with the following schools:

Magnus von Knebel Doeberitz's Academic­Influence.com Rankings

Why Is Magnus von Knebel Doeberitz Influential?

Magnus von Knebel Doeberitz's Published Works

Published Works

Other Resources About Magnus von Knebel Doeberitz

What Schools Are Affiliated With Magnus von Knebel Doeberitz?

Magnus von Knebel Doeberitz's AcademicInfluence.com Rankings